Amendis

AmendisAmendis
Amendis

Amendis

Amendis develops an AI-powered test to assess the risk of tumor spread in the neck, aiming to prevent unnecessary surgeries.

DR 1.82008Active55Tel Aviv, Israel
Rate

About

Amendis is a health tech company focused on developing innovative solutions for medical diagnostics. Their primary product is an AI-powered test designed to accurately assess the risk of tumor spread in the neck, with the goal of reducing the need for invasive and potentially unnecessary surgeries.
Frequently asked

What does Amendis do?

Amendis is a health tech company focused on developing innovative solutions for medical diagnostics. Their primary product is an AI-powered test designed to accurately assess the risk of tumor spread in the neck, with the goal of reducing the need for invasive and potentially unnecessary surgeries.

What is Amendis's revenue?

StartupHub estimates Amendis's annual revenue at $8.4M (range $4.8M to $16.9M, 64% confidence), based on comparable companies in the sector.

Where is Amendis headquartered?

Amendis is headquartered in Tel Aviv, Israel.

When was Amendis founded?

Amendis was founded in 2008.

What industry does Amendis operate in?

Amendis operates in Genomics, Healthcare, Diagnostics, Cancer, Metastasis, HealthTech.

How many employees does Amendis have?

Amendis has approximately 55 people on record.

HEADCOUNT
55
DOMAIN RATING
1.8
Comments

No comments yet. Be the first to share your take.